Dr. Xiaoping Wu, M.D.
Pulmonology (Pulmonary Disease Physician)
1725 W Harrison St Ste 10
Chicago, IL 60612
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- New York Medical College (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 453
Licensed in Illinois since 2021, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: New York Medical College
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
IL license 036158135 (first issued 2021; active) · NY license 273634
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Loyola University Medical Center Maywood, IL
- Loyola Gottlieb Memorial Hospital Melrose PArk, IL
- Macneal Hospital Berwyn, IL
Medical groups
- Loyola University Medical Center (953 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 453
- Services billed
- 1,210
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Test to determine lung volumes using sensors | 191 | 189 |
| Test to examine how well the lungs exchange gases | 191 | 189 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 177 | 82 |
| Test to measure rate of airflow | 165 | 162 |
| Critical care, first 30-74 minutes | 128 | 53 |
| Established patient office or other outpatient visit, 40-54 minutes | 82 | 60 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 74 | 73 |
| Established patient office or other outpatient visit, 30-39 minutes | 57 | 47 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 33 | 33 |
| New patient office or other outpatient visit, 60-74 minutes | 33 | 33 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Chicago, IL | 93 |
| Mycophenolate Mofetil Other prescribers in Chicago, IL | 88 |
| Prednisone Other prescribers in Chicago, IL | 74 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Chicago, IL | 60 |
| Ofev (nintedanib esylate) | 46 |
| Furosemide Other prescribers in Chicago, IL | 46 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Chicago, IL | 45 |
| Incruse Ellipta (umeclidinium bromide) Other prescribers in Chicago, IL | 37 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Chicago, IL | 33 |
| Azathioprine Other prescribers in Chicago, IL | 30 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $122 in total to this clinician.
| Boehringer Ingelheim Pharmaceuticals, Inc. | $122 |
|---|
| Food and Beverage | $122 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $6,396 in research payments for these studies, mostly to the institutions running them.
- Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
United Therapeutics Corporation · Completed · NCT04708782
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.